These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29298130)

  • 1. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
    Frazer IH
    Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 8. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
    Luxembourg A; Moeller E
    Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
    Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
    Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
    [No Abstract]   [Full Text] [Related]  

  • 10. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
    Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
    Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus and Associated Cancers: A Review.
    Jensen JE; Becker GL; Jackson JB; Rysavy MB
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human Papillomavirus: screening of cervical and anal cancers].
    Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
    Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus vaccine for women, and for men?
    Hidalgo Tenorio C
    Med Clin (Barc); 2019 Apr; 152(7):264-265. PubMed ID: 30591274
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.
    Luttjeboer J; Westra TA; Wilschut JC; Nijman HW; Daemen T; Postma MJ
    Vaccine; 2013 Aug; 31(37):3922-7. PubMed ID: 23806241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and burden of HPV-related disease.
    Serrano B; Brotons M; Bosch FX; Bruni L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of HPV Related Malignancies.
    Scott-Wittenborn N; Fakhry C
    Semin Radiat Oncol; 2021 Oct; 31(4):286-296. PubMed ID: 34455984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HPV: Carcinogenic implications and preventive measures].
    Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
    Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.